18.02.2014 • News

Clariant Said to Plan Exit from ASK Joint Venture With Ashland

Clariant is seeking to unload its stake in ASK Chemicals, a 50:50 joint venture with U.S.-based chemical producer Ashland, according to unconfirmed reports.

People familiar with the transaction told the news agency Reuters that several companies are interested, including private equity investor Sun Capital. Offers would be accepted until the end of February, the reports said.

Based at Hilden, near Düsseldorf, Germany, the company with 1,800 employees produces binding agents and additives for the foundry sector. Clariant has operative control.

Analysts said ASK could be valued at six to seven times the expected 2013 EBITDA of €40 million, which would give the chemical producer an enterprise value of €240-280 million.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read